20 - Azacitidine, Venetoclax, and Gilteritinib in FLT3-Mutated AML

Описание к видео 20 - Azacitidine, Venetoclax, and Gilteritinib in FLT3-Mutated AML

Discussão do artigo: "Azacitidine, Venetoclax, and Gilteritinib in Newly Diagnosed and Relapsed or Refractory FLT3-Mutated AML" de Short NJ J Clin Oncol 2024 Jan 26

Apresentado por: Dra. Fernanda Azevedo

Discussão por: Dr. Breno Aires, Dra. Thais Araujo, Dr. Caio Prato, Dra. Eurides Rosa, Dr. Pedro Arruda e Dr. Vinicius Molla.

Комментарии

Информация по комментариям в разработке